Sean Ellis - Net Worth and Insider Trading

Sean Ellis Net Worth

The estimated net worth of Sean Ellis is at least $175,612 dollars as of 2024-11-09. Sean Ellis is the Director of Entera Bio Ltd and owns about 102,100 shares of Entera Bio Ltd (ENTX) stock worth over $175,612. Details can be seen in Sean Ellis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Ellis has not made any transactions after 2023-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sean Ellis

To

Sean Ellis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean Ellis owns 1 companies in total, including Entera Bio Ltd (ENTX) .

Click here to see the complete history of Sean Ellis’s form 4 insider trades.

Insider Ownership Summary of Sean Ellis

Ticker Comapny Transaction Date Type of Owner
ENTX Entera Bio Ltd 2023-08-21 director

Sean Ellis Latest Holdings Summary

Sean Ellis currently owns a total of 1 stock. Sean Ellis owns 102,100 shares of Entera Bio Ltd (ENTX) as of August 21, 2023, with a value of $175,612.

Latest Holdings of Sean Ellis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTX Entera Bio Ltd 2023-08-21 102,100 1.72 175,612

Holding Weightings of Sean Ellis


Sean Ellis Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean Ellis has made a total of 4 transactions in Entera Bio Ltd (ENTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Entera Bio Ltd is the acquisition of 40,000 shares on August 21, 2023, which cost Sean Ellis around $24,000.

Insider Trading History of Sean Ellis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean Ellis Trading Performance

GuruFocus tracks the stock performance after each of Sean Ellis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean Ellis is 11.03%. GuruFocus also compares Sean Ellis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean Ellis within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sean Ellis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sean Ellis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.5 LIMIT LIMIT LIMIT LIMIT LIMIT

Sean Ellis Ownership Network

Ownership Network List of Sean Ellis

No Data

Ownership Network Relation of Sean Ellis

Insider Network Chart

Sean Ellis Owned Company Details

What does Entera Bio Ltd do?

Who are the key executives at Entera Bio Ltd?

Sean Ellis is the director of Entera Bio Ltd. Other key executives at Entera Bio Ltd include Israel CFO Dana Yaacov-garbeli , director & President of R&D Phillip Schwartz , and U.S.based CFO Ramesh Ratan .

Entera Bio Ltd (ENTX) Insider Trades Summary

Over the past 18 months, Sean Ellis made 1 insider transaction in Entera Bio Ltd (ENTX) with a net purchase of 40,000. Other recent insider transactions involving Entera Bio Ltd (ENTX) include a net purchase of 35,115 shares made by Haya Taitel , a net purchase of 43,952 shares made by Gerald M Lieberman , and a net purchase of 23,952 shares made by Miranda Jayne Toledano .

In summary, during the past 3 months, insiders sold 0 shares of Entera Bio Ltd (ENTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entera Bio Ltd (ENTX) were sold and 143,019 shares were bought by its insiders, resulting in a net purchase of 143,019 shares.

Entera Bio Ltd (ENTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entera Bio Ltd Insider Transactions

No Available Data

Sean Ellis Mailing Address

Above is the net worth, insider trading, and ownership report for Sean Ellis. You might contact Sean Ellis via mailing address: Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem L3 9112002.